About Clinical Trial Results
Clinical Trial Results (CTR) is a proven open-access format for rapidly sharing results of clinical trials regardless of outcome.
Motivated by the premise that every trial can have a benefit to the research community, CTR promotes the mission of sharing these results to speed discoveries. Offering a powerful solution for cooperation and transparency, CTR uses a menu-driven submission system that guides authors through a number of fields to distill trials to their key features. This enables fast-track publication, standardized reporting of results, and the global sharing of lessons learned. The streamlined format presents all of the essential information in a concise, easy to read report. No separate manuscript preparation is necessary.
CTR is suitable for any Phase I, II, or III trial. We welcome all submissions. While positive trials are desired, all trials are given equal consideration including trials that may not have met primary outcome endpoints or completed accrual. We believe all trials warrant online access in the global literature as part of good clinical practice.
Clinical Trial Results promotes data optimization through its unique and powerful platform that provides: 1) stylized content organization, 2) convenient original data handling, 3) optimized table/curve generation, including Waterfall plots and Kaplan-Meier curves.
Clinical Trial Results are published in a unique, two-part format:
- A brief Author Summary, to be published in print. This summary allows the reader to quickly grasp the aim and design of the study. It is made up of a structured abstract (200 words or less) containing four sections: Background, Methods, Results, and Conclusion; followed by a brief Discussion. This Discussion can take one of two forms:
- 350 words and two salient graphics, such as a table, schema, waterfall plot, image or graph
- 450 words with a single salient graphic
- The full data set, incorporating all supporting documentation and an extended Discussion, to be published online. Authors are allowed 1000 words for the extended online Discussion; they are encouraged to be thorough, yet concise. The sponsor, coordinating site, participating sites, and investigators should all be clearly identified.
The data published online remains the property of the author(s).
The Author Summary and the full Clinical Trial Results share a title and are PubMed citable with their own DOI (Document Object Identifier).
Join the mission of improving clinical trial design and efficiency by submitting results today.